1a) [25, 26]
However, when it was initially applied to the Chinese population, fasting-induced persistence fatigue and intense hunger were found to be the main obstacles to achieving therapeutic benefits [3]
Newer oral GLP-1 options like the Wegovy pill are more affordable currently around $149 per month but clinical trials show they deliver somewhat less weight loss than injectables, averaging around 1516% compared to 20% or more with injections. For patients who need significant weight loss to resolve health conditions, a lower-cost medication that produces fewer results may not be enough
Taken together, the translational potential for clinical applications for NTFs remains exciting, however, while strategies how to pass the BBB are on the horizon, little is known about potential deleterious consequences of NTFs in the complex neuroimmune crosstalk in MS for an early use in clinical studies
Vijiaratnam N, Girges C, Auld G, McComish R, King A, Skene SS, Hibbert S, Wong A, Melander S, Gibson R, Matthews H, Dickson J, Carroll C, Patrick A, Inches J, Silverdale M, Blackledge B, Whiston J, Hu M, Welch J et al (2025) Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
BPC Capsules and BPC/TB-500 Capsules are shelf-stable and need no refrigeration